Semaglutide 2.4mg weekly (STEP-1 trial) produced 14.9% mean body weight reduction at 68 weeks
The goal is to use these injections as part of a balanced approach, not as a sole reliance for weight loss
The peptide, derived from the C-terminal fragment of human growth hormone (amino acids 176-191), targets adipose tissue specifically without the broader metabolic effects associated with full growth hormone therapy
The review concluded that NNMT plays important roles in obesity and type 2 diabetes and validated 5-Amino-1MQ as a potent small-molecule NNMT inhibitor that reverses diet-induced metabolic changes, establishing it as a primary research tool for the NNMT pathway
Journal of Medicinal Chemistry (ACS) Bisubstrate inhibitors of NNMT with enhanced activity Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides